key: cord-1033744-7qjl1evz
authors: Nevel, Adam E.; Kline, Jeffrey A.
title: Inter‐rater reliability and prospective validation of a clinical prediction rule for SARS‐CoV‐2 infection
date: 2021-06-21
journal: Acad Emerg Med
DOI: 10.1111/acem.14309
sha: fe71c5958ca9297727fc1039aae47912972ea227
doc_id: 1033744
cord_uid: 7qjl1evz

OBJECTIVES: Accurate estimation of the risk of SARS‐CoV‐2 infection based on bedside data alone has importance to emergency department (ED) operations and throughput. The 13‐item CORC (COVID [or coronavirus] Rule‐out Criteria) rule had good overall diagnostic accuracy in retrospective derivation and validation. The objective of this study was to prospectively test the inter‐rater reliability and diagnostic accuracy of the CORC score and rule (score ≤ 0 negative, > 0 positive) and compare the CORC rule performance with physician gestalt. METHODS: This noninterventional study was conducted at an urban academic ED from February 2021 to March 2021. Two practitioners were approached by research coordinators and asked to independently complete a form capturing the CORC criteria for their shared patient and their gestalt binary prediction of the SARS‐CoV‐2 test result and confidence (0%–100%). The criterion standard for SARS‐CoV‐2 was from reverse transcriptase polymerase chain reaction performed on a nasopharyngeal swab. The primary analysis was from weighted Cohen's kappa and likelihood ratios (LRs). RESULTS: For 928 patients, agreement between observers was good for the total CORC score, κ = 0.613 (95% confidence interval [CI] = 0.579–0.646), and for the CORC rule, κ = 0.644 (95% CI = 0.591–0.697). The agreement for clinician gestalt binary determination of SARs‐CoV‐2 status was κ = 0.534 (95% CI = 0.437–0.632) with median confidence of 76% (first–third quartile = 66–88.5). For 425 patients who had the criterion standard, a negative CORC rule (both observers scored CORC < 0), the sensitivity was 88%, and specificity was 51%, with a negative LR (LR−) of 0.24 (95% CI = 0.10–0.50). Among patients with a mean CORC score of >4, the prevalence of a positive SARS‐CoV‐2 test was 58% (95% CI = 28%–85%) and positive LR was 13.1 (95% CI = 4.5–37.2). Clinician gestalt demonstrated a sensitivity of 51% and specificity of 86% with a LR− of 0.57 (95% CI = 0.39–0.74). CONCLUSION: In this prospective study, the CORC score and rule demonstrated good inter‐rater reliability and reproducible diagnostic accuracy for estimating the pretest probability of SARs‐CoV‐2 infection.

Emergency care clinical operations require accurate risk stratification for SARS-CoV-2 infection. This concern starts at the triage area in which practitioners (often nurses) must make time-sensitive decisions regarding safe placement of patients in the emergency department (ED). This necessity amplifies during times of "surge capacity" in which the number of active patients exceeds the number of ED rooms, forcing the consideration of nonideal patient care spaces, such as ED hallway beds, for infectious patients. Aimed at addressing this urgent need, the large body of recent literature addressing COVID-19 has included many decision rules for the prognosis of patients with suspected SARS-CoV-2 as well as decision rules that estimate of probability of SARS-CoV-2 infection using knowledge of laboratory and radiological data. [1] [2] [3] [4] [5] [6] [7] [8] However, far fewer studies have reported structured prediction rules designed to estimate the pretest probability of SARS-CoV-2 at the bedside without the use of laboratory or radiological imaging. [9] [10] [11] Additionally, only a handful of studies have accompanied these SARS-CoV-2 prediction rules with specific cutoffs that represent low-probability scenarios for which practitioners can forego diagnostic testing. [12] [13] [14] [15] [16] Fewer studies have examined the diagnostic accuracy of physician gestalt for SARS-CoV-2 infection. 17, 18 The studies that have been published on prediction have been criticized for high bias, and none have undergone full stages of validation. This includes (a) inter-rater reliability testing of the components; (b) overall categorization of pretest probability;

(c) independent, prospective diagnostic performance in real practice; and (d) comparison with physician gestalt. [19] [20] [21] To help address this gap, this report prospectively tests the interrater reliability and diagnostic accuracy of the CORC rule (COVID Rule-out Criteria) and compares its performance with physician gestalt. The CORC rule was derived and validated from data collected retrospectively from 19,850 patients, from 116 hospitals in 22 states using the RECOVER network. 22 The CORC rule consists of 13 component criteria, each scored with either a +1 (age > 50 years, Black race, Latin/Hispanic ethnicity, residential exposure to COVID-19, history of fever, history of myalgias, history of cough, history of loss of taste or smell, triage SpO 2 reading < 95%, triage temperature ≥ 38°C) or −1 (White race, no known exposure to COVID-19, current smoker). When compared against a criterion standard of reverse transcriptase polymerase chain reaction (rt-PCR) testing on a same-day nasopharyngeal swab sample, a CORC score of 0 or less produced a negative likelihood ratio (LR−) of 0.22 (95% confidence interval [CI] = 0.19-0.26) in the validation subset (n = 9,925). In this report, the primary goal is to assess the inter-rater reliability of a CORC score of 0 from prospectively assessed data in one ED in the United States in the spring of 2021. requirement was that all data had to be collected on the same day and protected health information could not be recorded. These requirements precluded any follow-up beyond the day of enrollment.

The primary objective of the study was to test inter-rater reliability, with a secondary objective to test the diagnostic accuracy of the CORC rule. The authors anticipate that the greatest value of CORC is as a screening tool in high-throughput areas, administered by any member of a health care team. Accordingly, the only exclusion criteria for patients was inability to communicate answers regarding symptoms required for CORC (recent fever, myalgia, or loss of taste or smell). For the purpose of testing diagnostic accuracy, we also in- 

The sample size was predicated on the primary outcome of the kappa (κ) coefficient, applied to the binary CORC rule negative or positive, which is defined as a CORC score of <0 or >0 points, respectively; we expected approximately a 50% distribution in each category. Therefore, by iterative calculation, to narrow the 95% CI around κ to <10% would require approximately 900 patients. Within this 900 we also sought to enroll approximately 400 patients who were tested for SARS-CoV-2 and expected 10% (40) to be positive, and based on the previous validation population, we expected 90% diagnostic sensitivity for the CORC rule, thus allowing the 95% CI around this proportion to be <10%.

The analysis refers to the CORC score as the total numeric value from the 13 items and the CORC rule as the binary result of CORC rule positive (>0) or negative (≤0). The primary analysis was the 

Paired forms from two providers were obtained from 928 patient encounters, completed by faculty (39%), residents (29%), nurses (15%), advanced practitioners (11%), research personnel (11%), and medical students (2%). Data from 10 encounters were excluded because one or more component of CORC score was missing. Figure 1 shows the breakdown of patients into four categories: patients known to be positive for SARS-CoV-2 within 14 days (n = 25), patients who tested positive for SARS-CoV-2 (n = 41, 9.6% prevalence), patients who tested negative for SARS-CoV-2 (n = 384), and those not tested but used for assessment of agreement (n = 468). Gestalt estimates from two clinicians were available for 741 encounters, including 415 with the criterion standard for SARS-CoV-2.

The raw agreement for the numeric CORC score was 53% and for the binary CORC rule was 84%. Table 1 presents the details of the main findings for agreement. Figure 2 shows a Bland-Altman plot for the difference between total CORC score versus the av- 

In the 425 patients who had the criterion standard, the overall diagnostic accuracy of the mean total CORC score from two observers as indicated by the AUROC (Figure 3 ) was 0.79 (95% CI = 0.70-0.88). Regarding the binary CORC rule performance, Table 2 95% CI = 61%-92%). Data Supplement S1 shows the sensitivity, specificity, and LR− for the 11 CORC components. Individually, none had a LR− lower than 0.60. Table 3 shows the same diagnostic indexes for gestalt as in Table 2 for the CORC rule result. While clinician gestalt clearly had higher specificity (86%, 95% CI = 82%-89%) than the CORC rule (51%, 95% CI = 46%-57%), clinician gestalt sensitivity was significantly lower at 51% (95% CI = 35%-68%), resulting in a significantly higher LR− 

This work tested the inter-rater reliability and diagnostic performance of a 13-component clinical prediction rule designed to assess the pretest probability for SARS-CoV-2 in undifferentiated patients using data commonly available at the bedside. From a total of 918 ED patients scored by two independent observers, we found good overall agreement for the raw CORC score (κ = 0.61, 95% CI = 0.58-0.65) and for the binary CORC rule (κ = 0.644, 95% CI = 0.591-0.697). Among the 425 patients who had the criterion standard of an rtPCR test for SARS-CoV-2 performed on a same-day nasopharyngeal swab, the CORC rule negative (i.e., a CORC score of 0 or less) had a sensitivity of 88%, specificity of 52%, and LR− of 0.24 (95% CI = 0.10-0.50), which is similar to the LR− found in the initial valida- estimates, including patients who tested positive and for whom they were wrong in almost half of cases.

To the best of our knowledge, this is the first clinical prediction rule to be tested prospectively, live in the ED setting. The CORC score originated from a national sample of 19,850 patients, randomly split in half for derivation then validation procedures. 15, 22 Other clinical prediction rules that were restricted to use of data available at the bedside have proposed three to 11 criteria in the rule, and all were derived on retrospective samples, but none have yet been tested for inter-rater reliability or diagnostic accuracy in an independently and retrospectively collected validation sample. [12] [13] [14] [15] [16] The CORC rule was designed for use in high-throughput areas where personnel could have access to a pulse oximeter and a thermometer, for example, in the triage area of the ED, but also possibly in intake areas for homeless shelters or extended-care facilities.

As more of the U.S. population becomes vaccinated against SARs-Cov-2, the subset of persons to which this will be most applicable will likely be those who remain unvaccinated. 

Limitations include the single-center design and convenience sample.

Whether the CORC score, or any other clinical prediction rule for SARS-CoV-2 infection, will remain relevant and accurate after mass vaccination represents an obvious potential limitation to the importance of this work. For example, the CORC score contains 13 components, all weighted equally, and it remains likely that some of these predictors will change in significance, as the underlying prevalence of infection decreases in response to vaccinations. Furthermore, these data were collected in early 2021 and the frequency with which observers marked yes to "household exposure to COVID-19" was only 3%, significantly lower than the 7.2% rate (95% CI = 6.8%-7.5%) that was recorded in the initial derivation and validation sample from 2020.

Likewise, we speculate that the driving forces behind the increased weighting of persons of color higher than that of White patients in the original sample from 2020 may diminish with higher vaccination rates and increased access to care. While children under 18 years of age were included in the original derivation and first validation of CORC, no children were represented in the present sample.

In conclusion, prospectively collected data indicate good inter-rater reliability and reproducible diagnostic accuracy of the CORC score and CORC rule for estimating the pretest probability of SARs-CoV-2

infection.

The authors thank Patti Hogan and Amanda Klimeck for administrative oversight of the RECOVER Network.

The authors have no potential conflicts to disclose.

Jeffrey A. Kline https://orcid.org/0000-0001-7190-3109

Predictors of COVID-19 severity: a systematic review and meta-analysis

Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study

A risk prediction score to identify patients at low risk for COVID-19 infection

A rapid screening classifier for diagnosing COVID-19

Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing

Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital

Ensemble learning model for diagnosing COVID-19 from routine blood tests

Derivation with internal validation of a multivariable predictive model to predict COVID-19 test results in emergency department patients

Diagnosing COVID-19 in the emergency department: a scoping review of clinical examinations, laboratory tests, imaging accuracy, and biases

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Clinical predictive models for COVID-19: systematic study

Clinical and epidemiological features discriminating confirmed COVID-19 patients from SARS-CoV-2 negative patients at screening centres in Madagascar

Proposed clinical indicators for efficient screening and testing for COVID-19 infection using Classification and Regression Trees (CART) analysis

COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2

Clinical prediction rule for SARS-CoV-2 infection from 116 U.S. emergency departments 2-22-2021

Derivation and internal validation of a model to predict the probability of severe acute respiratory syndrome coronavirus-2 infection in community people

Accuracy of emergency department clinical findings for diagnosis of coronavirus disease 2019

Diagnostic accuracy of physician's gestalt in suspected COVID-19: prospective bicentric study

COVID-19 prediction models should adhere to methodological and reporting standards

Can medical practitioners rely on prediction models for COVID-19? A systematic review

Methodologic standards for interpreting clinical decision rules in emergency medicine: 2014 update

Multicenter registry of United States emergency department patients tested for SARS-CoV-2

Trends in Number of COVID-19 Vaccinations in the US. Centers for Disease Control and Prevention. 2021. Accessed

Inter-rater reliability and prospective validation of a clinical prediction rule for SARS-CoV-2 infection